Footnote 15 — Earnings Per Share

The computations of the weighted average shares outstanding for the periods indicated are as follows (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Weighted-average shares outstanding		470.7		489.6		480.6		485.2
Share-based payment awards classified as participating securities (1)		0.3		0.8		0.5		1.1

Basic weighted-average shares outstanding		471.0		490.4		481.1		486.3
Dilutive securities (2)		—		1.1		—		1.6

Diluted weighted-average shares outstanding		471.0		491.5		481.1		487.9

(1)	For the three and nine months ended September 30, 2018 and 2017 dividends and equivalents for share-based awards that are expected to be forfeited do not have a material effect on net income for basic and diluted earnings per share.

(2)	The three and nine months ended September 30, 2018 excludes 0.3 million and 0.7 million potentially dilutive share-based awards as their effect would be anti-dilutive.

As of September 30, 2018, there were 1.7 million potentially dilutive restricted share awards with performance-based vesting targets that were not met and as such, have been excluded from the computation of diluted earnings per share.

At September 30, 2018, there were approximately 2.5 million shares of the Company’s common stock that had not been issued to the former holders of Jarden shares who are exercising their right to judicial appraisal under Delaware law. Absent consent by the Company, these dissenting shareholders are no longer entitled to the merger consideration, but are instead entitled only to the judicially determined fair value of their shares, plus interest accruing from the date of the acquisition of Jarden, payable in cash (see Footnote 19).

For the three and nine months ended September 30, 2018 and 2017 dividends per share were $0.23 and $0.23, respectively, and $0.69 and $0.65, respectively.